An official website of the United States government
Reported Tuberculosis in the United States, 2018
Table 45. Culture-Positive Tuberculosis Cases and Percentages with Drug-Susceptibility Results, by Resistance to Isoniazid or Multidrug Resistance: Reporting Areas, 2018
| Reporting Area | Total Culture Positive Cases | Cases with Initial Drug-Susceptibility Testing Performed1 | Resistance2 | ||||
| Isoniazid1 | Isoniazid and Rifampin1 | ||||||
| No. | (%) | No. | (%) | No. | (%) | ||
| United States | 7,081 | 6,442 | (91.0) | 605 | (9.4) | 98 | (1.5) |
| Alabama | 76 | 73 | (96.1) | 2 | (2.7) | 1 | (1.4) |
| Alaska | 47 | 47 | (100.0) | 5 | (10.6) | 0 | (0.0) |
| Arizona | 149 | 148 | (99.3) | 12 | (8.1) | 2 | (1.4) |
| Arkansas | 59 | 55 | (93.2) | 1 | (1.8) | 0 | (0.0) |
| California | 1,707 | 1,647 | (96.5) | 178 | (10.8) | 19 | (1.2) |
| Colorado | 50 | 50 | (100.0) | 6 | (12.0) | 0 | (0.0) |
| Connecticut | 47 | 47 | (100.0) | 6 | (12.8) | 3 | (6.4) |
| Delaware | 16 | 13 | (81.3) | 1 | (7.7) | 0 | (0.0) |
| District of Columbia | 26 | 26 | (100.0) | 0 | (0.0) | 0 | (0.0) |
| Florida | 493 | 482 | (97.8) | 30 | (6.2) | 3 | (0.6) |
| Georgia | 206 | 154 | (74.8) | 7 | (4.5) | 2 | (1.3) |
| Hawaii | 98 | 95 | (96.9) | 12 | (12.6) | 1 | (1.1) |
| Idaho | 11 | 11 | (100.0) | 2 | (18.2) | 0 | (0.0) |
| Illinois | 216 | 210 | (97.2) | 23 | (11.0) | 2 | (1.0) |
| Indiana | 86 | 84 | (97.7) | 5 | (6.0) | 2 | (2.4) |
| Iowa | 31 | 31 | (100.0) | 1 | (3.2) | 0 | (0.0) |
| Kansas | 25 | 25 | (100.0) | 3 | (12.0) | 1 | (4.0) |
| Kentucky | 50 | 47 | (94.0) | 4 | (8.5) | 2 | (4.3) |
| Louisiana | 87 | 85 | (97.7) | 4 | (4.7) | 0 | (0.0) |
| Maine | 7 | 7 | (100.0) | 1 | (14.3) | 0 | (0.0) |
| Maryland | 164 | 159 | (97.0) | 16 | (10.1) | 3 | (1.9) |
| Massachusetts | 158 | 155 | (98.1) | 19 | (12.3) | 1 | (0.6) |
| Michigan | 67 | 67 | (100.0) | 8 | (11.9) | 4 | (6.0) |
| Minnesota | 136 | 131 | (96.3) | 16 | (12.2) | 7 | (5.3) |
| Mississippi | 59 | 54 | (91.5) | 3 | (5.6) | 0 | (0.0) |
| Missouri | 45 | 14 | (31.1) | 2 | (14.3) | 0 | (0.0) |
| Montana | 4 | 4 | (100.0) | 0 | (0.0) | 0 | (0.0) |
| Nebraska | 18 | 15 | (83.3) | 0 | (0.0) | 0 | (0.0) |
| Nevada | 55 | 55 | (100.0) | 6 | (10.9) | 0 | (0.0) |
| New Hampshire | 12 | 12 | (100.0) | 0 | (0.0) | 0 | (0.0) |
| New Jersey | 239 | 230 | (96.2) | 20 | (8.7) | 7 | (3.0) |
| New Mexico | 31 | 30 | (96.8) | 3 | (10.0) | 0 | (0.0) |
| New York State3 | 151 | 126 | (83.4) | 15 | (11.9) | 2 | (1.6) |
| New York City | 423 | 406 | (96.0) | 49 | (12.1) | 12 | (3.0) |
| North Carolina | 164 | 159 | (97.0) | 8 | (5.0) | 1 | (0.6) |
| North Dakota | 8 | 7 | (87.5) | 3 | (42.9) | 0 | (0.0) |
| Ohio | 124 | 121 | (97.6) | 4 | (3.3) | 2 | (1.7) |
| Oklahoma | 57 | 57 | (100.0) | 5 | (8.8) | 4 | (7.0) |
| Oregon | 62 | 61 | (98.4) | 9 | (14.8) | 0 | (0.0) |
| Pennsylvania | 174 | 164 | (94.3) | 15 | (9.1) | 2 | (1.2) |
| Rhode Island | 13 | 12 | (92.3) | 5 | (41.7) | 1 | (8.3) |
| South Carolina | 71 | 69 | (97.2) | 3 | (4.3) | 2 | (2.9) |
| South Dakota | 10 | 10 | (100.0) | 0 | (0.0) | 0 | (0.0) |
| Tennessee | 91 | 89 | (97.8) | 7 | (7.9) | 0 | (0.0) |
| Texas | 871 | 516 | (59.2) | 44 | (8.5) | 3 | (0.6) |
| Utah | 15 | 15 | (100.0) | 2 | (13.3) | 1 | (6.7) |
| Vermont | 4 | 4 | (100.0) | 1 | (25.0) | 0 | (0.0) |
| Virginia | 160 | 160 | (100.0) | 15 | (9.4) | 3 | (1.9) |
| Washington | 160 | 156 | (97.5) | 19 | (12.2) | 3 | (1.9) |
| West Virginia | 3 | 3 | (100.0) | 0 | (0.0) | 0 | (0.0) |
| Wisconsin | 44 | 43 | (97.7) | 5 | (11.6) | 2 | (4.7) |
| Wyoming | 1 | 1 | 100 | 0 | 0 | 0 | 0 |
| American Samoa4 | 1 | 0 | (0.0) | 0 | … | 0 | … |
| Fed. States of Micronesia4 | — | — | — | — | — | — | — |
| Guam4 | 47 | 46 | (97.9) | 3 | (6.5) | 0 | (0.0) |
| Marshall Islands4 | — | — | — | — | — | — | — |
| N. Mariana Islands4 | 15 | 15 | (100.0) | 2 | (13.3) | 1 | (6.7) |
| Puerto Rico4 | 19 | 19 | (100.0) | 0 | (0.0) | 0 | (0.0) |
| Republic of Palau4 | 13 | 12 | (92.3) | 0 | (0.0) | 0 | (0.0) |
| U.S. Virgin Islands4 | 0 | 0 | … | 0 | … | 0 | … |
1Patients tested to at least isoniazid and rifampin.
2Isolates may be resistant to other drugs. Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and the District of Columbia).
3Excludes New York City.
4Not included in U.S. totals.
Note: Ellipses (…) indicate that the percentage cannot be calculated, and the denominator is 0.
Emdashes (—) indicate that data are not available.